Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity

Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.

6,786 public trials 654 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity trial results

Completed

A Study of CDX-0159 in Patients With Chronic Inducible Urticaria

NCT05405660

Conditions
Chronic Disease, Chronic Inducible Urticaria, Chronic Urticaria, +10 more
Locations
  • Clinical Research Center of Alabama Birmingham, Alabama, United States
  • Allervie Clinical Research Montgomery, Alabama, United States
  • One of a Kind Clinical Research Center, LLC Paradise Valley, Arizona, United States
  • Little Rock Allergy & Asthma CRC Little Rock, Arkansas, United States
View all 76 locations
View Trial Details
Completed

Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)

NCT04392154

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Pinnacle Research Group, LLC Anniston, Alabama, United States
  • Clinical Research Center of Alabama- Birmingham Birmingham, Alabama, United States
  • Investigate MD Scottsdale, Arizona, United States
  • Johnson Dermatology Fort Smith, Arkansas, United States
View all 321 locations
View Trial Details
Completed

Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE)

NCT04394351

Conditions
Digestive System Diseases, Eosinophilia, Eosinophilic Esophagitis, +11 more
Locations
  • Regeneron Study Site Phoenix, Arizona, United States
  • Regeneron Study Site Little Rock, Arkansas, United States
  • Regeneron Study Site Los Angeles, California, United States
  • Regeneron Study Site San Francisco, California, United States
View all 27 locations
View Trial Details
Completed

EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients

NCT04998604

Conditions
Asthma, Bronchial Diseases, Chronic Rhinosinusitis With Nasal Polyps, +7 more
Locations
  • Cedars Sinai Medical Center Site Number : 8400026 Los Angeles, California, United States
  • Asthma Allergy & Immunology Clinical Research Unit Site Number : 8400027 Tampa, Florida, United States
  • Northwestern University Site Number : 8400001 Chicago, Illinois, United States
  • University of Illinois Chicago, Illinois, United States
View all 87 locations
View Trial Details

Related conditions